Varespladib methyl
- Generic Name
- Varespladib methyl
- Drug Type
- Small Molecule
- Chemical Formula
- C22H22N2O5
- CAS Number
- 172733-08-3
- Unique Ingredient Identifier
- 0NB98NBX3D
Overview
Varespladib methyl has been investigated for the treatment of Acute Coronary Syndrome. Studies showed that Varespladib methyl treatment resulted in significant positive changes on lipoproteins and inflammation.
Background
Varespladib methyl has been investigated for the treatment of Acute Coronary Syndrome. Studies showed that Varespladib methyl treatment resulted in significant positive changes on lipoproteins and inflammation.
Indication
Investigated for use/treatment in atherosclerosis and coronary artery disease.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath